Allspring Global Investments Holdings, LLC Cytek Biosciences, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 929 shares of CTKB stock, worth $5,694. This represents 0.0% of its overall portfolio holdings.
Number of Shares
929
Previous 25,144
96.31%
Holding current value
$5,694
Previous $140,000
96.43%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CTKB
# of Institutions
135Shares Held
72.2MCall Options Held
400Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$105 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$72.2 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD9.49MShares$58.2 Million1.15% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$40.8 Million0.85% of portfolio
-
State Street Corp Boston, MA4.17MShares$25.5 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $825M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...